Swedish Orphan Biovitrum AB (BIOVF)
51.05
0.00 (0.00%)
USD |
OTCM |
Nov 17, 16:00
Swedish Orphan Biovitrum Enterprise Value : 19.28B for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 19.28B |
| November 16, 2026 | 19.28B |
| November 13, 2026 | 19.28B |
| November 12, 2026 | 19.28B |
| November 11, 2026 | 19.28B |
| November 10, 2026 | 19.28B |
| November 09, 2026 | 19.28B |
| November 06, 2026 | 17.43B |
| November 05, 2026 | 17.43B |
| November 04, 2026 | 17.43B |
| November 03, 2026 | 17.43B |
| November 02, 2026 | 17.43B |
| October 30, 2026 | 17.43B |
| October 29, 2026 | 17.43B |
| October 28, 2026 | 17.43B |
| October 27, 2026 | 17.43B |
| October 26, 2026 | 17.43B |
| October 23, 2026 | 17.43B |
| October 22, 2026 | 17.53B |
| October 21, 2026 | 17.53B |
| October 20, 2026 | 16.41B |
| October 19, 2026 | 16.41B |
| October 16, 2026 | 16.41B |
| October 15, 2026 | 16.41B |
| October 14, 2026 | 16.41B |
| Date | Value |
|---|---|
| October 13, 2026 | 16.41B |
| October 12, 2026 | 16.41B |
| October 09, 2026 | 16.41B |
| October 08, 2026 | 16.41B |
| October 07, 2026 | 16.41B |
| October 06, 2026 | 16.41B |
| October 05, 2026 | 16.45B |
| October 02, 2026 | 16.45B |
| October 01, 2026 | 16.45B |
| September 30, 2026 | 16.45B |
| September 29, 2026 | 16.60B |
| September 28, 2026 | 18.42B |
| September 25, 2026 | 18.42B |
| September 24, 2026 | 18.42B |
| September 23, 2026 | 18.42B |
| September 22, 2026 | 18.42B |
| September 21, 2026 | 18.42B |
| September 18, 2026 | 18.42B |
| September 17, 2026 | 18.42B |
| September 16, 2026 | 18.42B |
| September 15, 2026 | 18.42B |
| September 14, 2026 | 18.42B |
| September 11, 2026 | 18.42B |
| September 10, 2026 | 18.42B |
| September 09, 2026 | 18.42B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hansa Biopharma AB | 289.13M |
| BioArctic AB | 2.495B |
| Diamyd Medical AB | 87.03M |
| BONESUPPORT HOLDING AB | 2.028B |
| BioInvent International AB | -2.156M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 243.36M |
| Revenue (Quarterly) | 945.26M |
| Total Expenses (Quarterly) | 701.80M |
| EPS Diluted (Quarterly) | 0.6926 |
| Gross Profit Margin (Quarterly) | 70.48% |
| Profit Margin (Quarterly) | 25.75% |
| Earnings Yield | 3.93% |
| Operating Earnings Yield | 5.77% |
| Normalized Earnings Yield | 4.240 |